GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is rapidly becoming a major focus in healthcare investigation, largely due to its remarkable impact on controlling conditions such as adult-onset diabetes and weight gain. Ongoing trials have revealed that beyond glucose regulation, GLP-